FOSteR: A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez (clinicaltrials.gov) - Sep 29, 2026 - P=N/A | N=170 | Recruiting | Sponsor: Chiesi Farmaceutici S.p.A. | N=580 ➔ 170
Enrollment change • Genetic Disorders • Oncology • Skin Cancer
|